Thomas Odeny, MD, MPH, PhD

Medical Oncologist

Thomas Odeny

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Clinical Expertise

  • Medical oncology, HIV-associated malignancies, lymphoma, Kaposi sarcoma, anal cancer, immunocompromised populations with cancer, global cancer care delivery. 

     

Primary Academic Title

Assistant Professor of Medicine, Division of Medical Oncology, WashU Medicine

Board Certification

  • 2020: American Board of Internal Medicine
  • 2023: American Board of Internal Medicine, Board Certified in Medical Oncology

Training

  • 2011 - 2012: Clinical Research Fellow, NIH/Fogarty International Center, Bethesda, MD
  • 2012 - 2013: Senior/Post-Graduate Fellow, Institute for Health Metrics and Evaluation, Seattle, WA
  • 2017 - 2020: Resident, Internal Medicine, University of Missouri, Kansas City, MO
  • 2020 - 2022: Clinical Fellow, Medical Oncology, NIH/National Cancer Institute, Bethesda, MD

Education

  • 2006: MD, University of Nairobi, Kenya
  • 2011: MPH, University of Washington, Seattle, WA
  • 2016: PhD, University of Washington, Seattle, WA

Research & Selected Publications

Research Interest

Clinical trials in virus-associated cancers, cancer in people with HIV, implementation science, digital tools for cancer detection and monitoring, community-engaged and inclusive clinical trial design, global oncology.

Research Publications

Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee
Authors:

Dent J, Jorge M, Sobrevilla N, one or more additional authors omitted Odeny TA, one or more additional authors omitted Kaufman DR

Journal & Year:

J Immunother Cancer | 2025

Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma
Authors:

Lurain K, Ramaswami R, Ekwede I, one or more additional authors omitted Odeny TA, one or more additional authors omitted Uldrick TS

Journal & Year:

J Clin Oncol | 2025

Cancer in People with HIV
Authors:

Odeny TA, Fink V, Muchengeti M, Gopal S

Journal & Year:

Infect Dis Clin North Am | 2024